Instil Bio (TIL) Gains from Investment Securities (2020 - 2025)
Instil Bio (TIL) posted quarterly Gains from Investment Securities of -$948000.0 for Q4 2025, up 32.77% year-over-year from -$714038.5 in Q4 2024, and up 32.77% quarter-over-quarter from -$1.4 million in Q4 2024.
Instil Bio (TIL) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Instil Bio's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$948000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 32.77% year-over-year to -$948000.0; the TTM figure through Dec 2025 stood at -$948000.0 (up 75.75% YoY), while the FY2025 annual figure was -$948000.0, up 75.75% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$948000.0, up from -$1.4 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $272000.0 in Q3 2022, with the low at -$3.3 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is -$236000.0 (2023), against an average of -$636882.4.
- The sharpest annual moves came in 2021 and 2024: Gains from Investment Securities surged 153.03% in 2021, then slumped 6840.0% in 2024.
- Instil Bio's Gains from Investment Securities stood at $164000.0 in 2021, then sank by 1434.15% to -$2.2 million in 2022, then tumbled by 52.79% to -$3.3 million in 2023, then soared by 57.82% to -$1.4 million in 2024, then surged by 32.77% to -$948000.0 in 2025.
- Business Quant data shows TIL's Gains from Investment Securities at -$948000.0 in Q4 2025, -$1.4 million in Q4 2024, and -$2.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -948,000.00 |
| Dec 31, 2025 | -948,000.00 |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Jun 30, 2024 | 99,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Dec 31, 2023 | -3.34 Mn |
| Dec 31, 2023 | -3.34 Mn |
| Sep 30, 2023 | 40,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 155,000.00 |
| Mar 31, 2023 | -236,000.00 |
| Mar 31, 2023 | -236,000.00 |
| Dec 31, 2022 | -2.19 Mn |
| Dec 31, 2022 | -2.19 Mn |